S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Walmart’s uptrend is intact; buy it when it dips
Does Datadog have huge potential?
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Walmart’s uptrend is intact; buy it when it dips
Does Datadog have huge potential?
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Walmart’s uptrend is intact; buy it when it dips
Does Datadog have huge potential?
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Walmart’s uptrend is intact; buy it when it dips
Does Datadog have huge potential?

Adverum Biotechnologies (ADVM) Short Interest Ratio & Short Volume

$1.96
-0.07 (-3.45%)
(As of 02/20/2024 ET)

Adverum Biotechnologies Short Interest Data

Current Short Volume
1,220,000 shares
Previous Short Volume
1,650,000 shares
Change Vs. Previous Month
-26.06%
Dollar Volume Sold Short
$1.28 million
Short Interest Ratio / Days to Cover
0.9
Last Record Date
January 31, 2024
Outstanding Shares
101,030,000 shares
Float Size
87,540,000 shares
Short Percent of Float
1.39%
Today's Trading Volume
1,295,312 shares
Average Trading Volume
2,770,866 shares
Today's Volume Vs. Average
47%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Adverum Biotechnologies ?

Sign up to receive the latest short interest report for Adverum Biotechnologies and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ADVM Short Interest Over Time

ADVM Days to Cover Over Time

ADVM Percentage of Float Shorted Over Time


Adverum Biotechnologies Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/20241,220,000 shares $1.28 million -26.1%1.4%0.9 $1.05
1/15/20241,650,000 shares $1.40 million -2.4%1.9%4.4 $0.85
12/31/20231,690,000 shares $1.27 million +7.6%1.9%5.6 $0.75
12/15/20231,570,000 shares $1.28 million +5.4%1.8%5.8 $0.82
11/30/20231,490,000 shares $1.20 million No Change1.7%5.9 $0.81
11/15/20231,490,000 shares $1.31 million +10.4%1.7%6.4 $0.88
10/31/20231,350,000 shares $1.21 million +4.7%1.5%5.6 $0.90
10/15/20231,290,000 shares $1.26 million +15.2%1.5%4.6 $0.98
9/30/20231,120,000 shares $1.68 million -16.4%1.3%3.2 $1.50
9/15/20231,340,000 shares $2.09 million +20.7%1.5%3.1 $1.56
8/31/20231,110,000 shares $1.93 million +5.7%1.3%2.2 $1.74
8/15/20231,050,000 shares $1.88 million +10.5%1.2%1.9 $1.79
7/31/2023950,000 shares $2.07 million -13.6%1.0%1.8 $2.18
7/15/20231,100,000 shares $2.21 million -17.9%1.1%2.1 $2.01
6/30/20231,340,000 shares $2.13 million -14.1%1.4%2.9 $1.59
6/15/20231,560,000 shares $2.28 million +5.4%1.6%3.5 $1.46
5/31/20231,480,000 shares $1.82 million +2.8%1.5%3.4 $1.23
5/15/20231,440,000 shares $1.19 million -0.7%1.5%3.6 $0.83
4/30/20231,450,000 shares $1.14 million -4.0%1.6%3.4 $0.78
4/15/20231,510,000 shares $1.27 million -2.0%1.7%3.2 $0.84
3/31/20231,540,000 shares $1.10 million -3.1%1.7%3.5 $0.72
3/15/20231,590,000 shares $1.30 million +1.9%1.8%3 $0.82
2/28/20231,560,000 shares $1.12 million No Change1.7%3.3 $0.72
2/15/20231,560,000 shares $970,788.00 -0.6%1.7%2.9 $0.62
1/31/20231,570,000 shares $1.02 million -12.3%1.7%2.7 $0.65
1/15/20231,790,000 shares $1.22 million -8.2%2.0%3.2 $0.68
12/30/20221,950,000 shares $1.13 million -8.9%2.1%3.5 $0.58
12/15/20222,140,000 shares $1.35 million -11.9%2.4%3.9 $0.63
11/30/20222,430,000 shares $1.63 million No Change2.7%4.8 $0.67
11/15/20222,430,000 shares $1.70 million -5.8%2.7%4.8 $0.70
10/31/20222,580,000 shares $2.23 million -2.6%2.9%5.8 $0.87
10/15/20222,650,000 shares $2.46 million -0.4%2.9%6 $0.93
9/30/20222,660,000 shares $2.53 million +7.7%3.0%3.8 $0.95
9/15/20222,470,000 shares $2.72 million No Change2.7%2.3 $1.10
8/31/20222,470,000 shares $2.87 million -4.6%2.7%2.1 $1.16
8/15/20222,590,000 shares $3.65 million -15.4%2.9%2.1 $1.41
7/31/20223,060,000 shares $4.47 million -13.3%3.4%2.3 $1.46
7/15/20223,530,000 shares $5.82 million -12.8%3.9%2.5 $1.65
6/30/20224,050,000 shares $4.86 million -25.7%4.5%3 $1.20
6/15/20225,450,000 shares $5.29 million -4.1%6.1%4.1 $0.97













ADVM Short Interest - Frequently Asked Questions

What is Adverum Biotechnologies' current short interest?

Short interest is the volume of Adverum Biotechnologies shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 1,220,000 shares of ADVM short. 1.39% of Adverum Biotechnologies' shares are currently sold short. Learn More on Adverum Biotechnologies' current short interest.

What is a good short interest ratio for Adverum Biotechnologies?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADVM shares currently have a short interest ratio of 1.0. Learn More on Adverum Biotechnologies's short interest ratio.

Which institutional investors are shorting Adverum Biotechnologies?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Adverum Biotechnologies: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Adverum Biotechnologies?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.39% of Adverum Biotechnologies' floating shares are currently sold short.

Is Adverum Biotechnologies' short interest increasing or decreasing?

Adverum Biotechnologies saw a drop in short interest in January. As of January 31st, there was short interest totaling 1,220,000 shares, a drop of 26.1% from the previous total of 1,650,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Adverum Biotechnologies' float size?

Adverum Biotechnologies currently has issued a total of 101,030,000 shares. Some of Adverum Biotechnologies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Adverum Biotechnologies currently has a public float of 87,540,000 shares.

How does Adverum Biotechnologies' short interest compare to its competitors?

1.39% of Adverum Biotechnologies' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Adverum Biotechnologies: INmune Bio, Inc. (9.97%), Scilex Holding (7.36%), Black Diamond Therapeutics, Inc. (4.65%), Monte Rosa Therapeutics, Inc. (6.05%), Omega Therapeutics, Inc. (14.67%), Fennec Pharmaceuticals Inc (9.14%), Kodiak Sciences Inc. (3.21%), Innate Pharma S.A. (0.09%), Jasper Therapeutics, Inc. (3.42%), Gritstone bio, Inc. (10.39%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Adverum Biotechnologies stock?

Short selling ADVM is an investing strategy that aims to generate trading profit from Adverum Biotechnologies as its price is falling. ADVM shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Adverum Biotechnologies?

A short squeeze for Adverum Biotechnologies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADVM, which in turn drives the price of the stock up even further.

How often is Adverum Biotechnologies' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADVM, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ADVM) was last updated on 2/21/2024 by MarketBeat.com Staff